OraSure CEO Buys 32,300 Shares, Increasing Stake by 1.5%

Manner Carrie Eglinton's purchase comes as company reports Q4 earnings miss and carries 'Reduce' rating from analysts.

Mar. 24, 2026 at 8:38am

Got story updates? Submit your updates here. ›

Manner Carrie Eglinton, the CEO of OraSure Technologies, Inc. (NASDAQ:OSUR), purchased 32,300 shares of the company's stock on March 20th at an average price of $2.93 per share, totaling around $94,639. This transaction increased Eglinton's ownership stake in OraSure by 1.5% to 2,190,874 shares, valued at approximately $6.42 million.

Why it matters

The insider buying by the CEO signals her confidence in the company's future prospects, despite OraSure's recent Q4 earnings miss and the overall 'Reduce' rating from Wall Street analysts. Institutional investors already hold a significant 93.5% stake in the company, and some major hedge funds have been increasing their positions.

The details

OraSure, a medical diagnostics company, reported Q4 earnings on February 25th, missing analyst estimates with EPS of -$0.19 against a -$0.17 forecast. The company generated $26.76 million in revenue and had a negative net margin of around 59.8%. Eglinton's latest purchase follows another 22,022 share buy on March 13th at $3 per share.

  • On March 20, 2026, Manner Carrie Eglinton purchased 32,300 shares of OraSure Technologies stock.
  • On March 13, 2026, Manner Carrie Eglinton acquired 22,022 shares of OraSure Technologies stock.

The players

Manner Carrie Eglinton

The CEO of OraSure Technologies, Inc.

OraSure Technologies, Inc.

A medical diagnostics company that specializes in the development, manufacture and commercialization of point-of-care and self-testing products.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

Eglinton's insider buying suggests she sees value in OraSure's long-term prospects, even as the company faces near-term challenges like the Q4 earnings miss. The significant institutional ownership and recent hedge fund activity also point to investor confidence in the company's future direction.